Benefit/risk for adjuvant breast cancer therapy with tamoxifen or aromatase inhibitor use by age, and race/ethnicity

Overview of attention for article published in Breast Cancer Research and Treatment, November 2015

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 4 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 47 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Breast Cancer Surveillance Consortium, 03 Dec 2015

Great study from the Women's Health Initiative weighing risks and benefits of tamoxifen and aromatase inhibitor treatment: http:…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.